Novel bis-, tris-, and tetrakis-tertiary amino analogs as antagonists at neuronal nicotinic receptors that mediate nicotine-evoked dopamine release
作者:Zhenfa Zhang、Guangrong Zheng、Marharyta Pivavarchyk、A. Gabriela Deaciuc、Linda P. Dwoskin、Peter A. Crooks
DOI:10.1016/j.bmcl.2010.11.070
日期:2011.1
A series of tertiaryamine analogs derived from lead azaaromatic quaternaryammoniumsalts has been designed and synthesized. The bis-tertiary amine analog exhibited an IC of 0.95nM, while the tris-tertiary amine analog had an IC of 0.35nM at nAChRs mediating nicotine-evoked dopamine release.
设计并合成了一系列由氮杂芳族铅季铵盐衍生的叔胺类似物。双叔胺类似物对介导尼古丁诱发多巴胺释放的 nAChR 的 IC 值为 0.95nM,而三叔胺类似物的 IC 值为 0.35nM。
USE OF TRIS-QUATERNARY AMMONIUM SALTS AS PAIN MODULATING AGENTS
申请人:HOLTMAN Joseph R.
公开号:US20100120857A1
公开(公告)日:2010-05-13
Provided are tris-quaternary ammonium compounds which are modulators of nociception and pain.
提供的是三元四元铵化合物,它们是痛觉和疼痛的调节剂。
TRIS-QUARTERNARY AMMONIUM SALTS AND METHODS FOR MODULATING NEURONAL NICOTINIC ACETYLCHOLINE RECEPTORS
申请人:Crooks Peter A.
公开号:US20110105556A1
公开(公告)日:2011-05-05
Provided are tris-quaternary ammonium compounds which are modulators of nicotinic acetylocholine receptors. Also provided are methods of using the compounds for modulating the function of a nicotinic acetylcholine receptor, and for the prevention and/or treatment of central nervous system disorders, substance use and/or abuse and or gastrointestinal tract disorders.
Tris-Quaternary Ammonium Salts and Methods for Modulating Neuronal Nicotinic Acetylcholine Receptors
申请人:University of Kentucky Research Foundation
公开号:US20130030018A1
公开(公告)日:2013-01-31
Provided are tris-quaternary ammonium compounds which are modulators of nicotinic acetylocholine receptors. Also provided are methods of using the compounds for modulating the function of a nicotinic acetylcholine receptor, and for the prevention and/or treatment of central nervous system disorders, substance use and/or abuse and or gastrointestinal tract disorders.
Use of a Novel Alpha-7 Nachr Antagonist to Suppress Pathogenic Signal Transduction in Cancer and Aids
申请人:UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION
公开号:US20130231366A1
公开(公告)日:2013-09-05
This application provides a method for the use of select quaternary ammonium antagonists to alpha-7 nAChR for the treatment of cancer and HIV and AIDS.